메뉴 건너뛰기
Journal of Virology
Volumn 79, Issue 13, 2005, Pages 8454-8469
Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors
Author keywords

[No Author keywords available]
Indexed keywords

4 [1 [(2,4 DIMETHYL 3 PYRIDINYL)CARBONYL] 4 METHYL 4 PIPERIDINYL] 2 METHYL 1 [1 [4 (TRIFLUOOROMETHYL)PHENYL]ETHYL]PIPERAZINE; ANTIVIRUS AGENT; CD4 IMMUNOGLOBULIN G2; CHEMOKINE RECEPTOR CCR5; ENFUVIRTIDE; ENZYME INHIBITOR; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G1 ANTIBODY; INHIBITOR PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY 4E10; NEUTRALIZING ANTIBODY; PRO 140; RANTES; UNCLASSIFIED DRUG;
EID: 20744442398     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.13.8454-8469.2005     Document Type: Article
Times cited : (68)
References (107)
  • 3
    • 0025886458 scopus 로고
    • Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity
    • Erratum, 89: 1517
    • Ashkenazi, A., D. H. Smith, S. A. Marsters, L. Riddle, T. J. Gregory, D. D. Ho, and D. J. Capon. 1991. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proc. Natl. Acad. Sci. USA 88:7056-7060. (Erratum, 89: 1517.)
    • (1991) Proc. Natl. Acad. Sci. USA , vol.88 , pp. 7056-7060
    • Ashkenazi, A.1    Smith, D.H.2    Marsters, S.A.3    Riddle, L.4    Gregory, T.J.5    Ho, D.D.6    Capon, D.J.7
  • 6
    • 0033894973 scopus 로고    scopus 로고
    • Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees
    • Beaumont, T., S. Broersen, A. van Nuenen, H. G. Huisman, A. M. Roda Husman, J. L. Heeney, and H. Schuitemaker. 2000. Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees. J. Virol. 74:7699-7707.
    • (2000) J. Virol. , vol.74 , pp. 7699-7707
    • Beaumont, T.1    Broersen, S.2    Van Nuenen, A.3    Huisman, H.G.4    Roda Husman, A.M.5    Heeney, J.L.6    Schuitemaker, H.7
  • 7
    • 2442671600 scopus 로고    scopus 로고
    • Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization- resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker
    • Beaumont, T., E. Quakkelaar, A. van Nuenen, R. Pantophlet, and H. Schuitemaker. 2004. Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker. J. Virol. 78:5651-5657.
    • (2004) J. Virol. , vol.78 , pp. 5651-5657
    • Beaumont, T.1    Quakkelaar, E.2    Van Nuenen, A.3    Pantophlet, R.4    Schuitemaker, H.5
  • 8
    • 0035128422 scopus 로고    scopus 로고
    • Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course
    • Beaumont, T., A. van Nuenen, S. Broersen, W. A. Blattner, V. V. Lukashov, and H. Schuitemaker. 2001. Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course. J. Virol. 75: 2246-2252.
    • (2001) J. Virol. , vol.75 , pp. 2246-2252
    • Beaumont, T.1    Van Nuenen, A.2    Broersen, S.3    Blattner, W.A.4    Lukashov, V.V.5    Schuitemaker, H.6
  • 9
    • 0027957921 scopus 로고
    • Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides
    • Bernstein, H. B., S. P. Tucker, E. Hunter, J. S. Schutzbach, and R. W. Compans. 1994. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 68:463-468.
    • (1994) J. Virol. , vol.68 , pp. 463-468
    • Bernstein, H.B.1    Tucker, S.P.2    Hunter, E.3    Schutzbach, J.S.4    Compans, R.W.5
  • 10
    • 0030897105 scopus 로고    scopus 로고
    • Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1
    • Binley, J. M., P. J. Klasse, Y. Cao, I. Jones, M. Markowitz, D. D. Ho, and J. P. Moore. 1997. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J. Virol. 71: 2799-2809.
    • (1997) J. Virol. , vol.71 , pp. 2799-2809
    • Binley, J.M.1    Klasse, P.J.2    Cao, Y.3    Jones, I.4    Markowitz, M.5    Ho, D.D.6    Moore, J.P.7
  • 11
    • 0033823590 scopus 로고    scopus 로고
    • The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection
    • Binley, J. M., A. Trkola, T. Ketas, D. Schiller, B. Clas, S. Little, D. Richman, A. Hurley, M. Markowitz, and J. P. Moore. 2000. The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection. J. Infect. Dis. 182:945-949.
    • (2000) J. Infect. Dis. , vol.182 , pp. 945-949
    • Binley, J.M.1    Trkola, A.2    Ketas, T.3    Schiller, D.4    Clas, B.5    Little, S.6    Richman, D.7    Hurley, A.8    Markowitz, M.9    Moore, J.P.10
  • 12
    • 17144456021 scopus 로고    scopus 로고
    • The antibody response in HIV-1 infection
    • Burton, D. R., and D. C. Montefiori. 1997. The antibody response in HIV-1 infection. AIDS 11:87-98.
    • (1997) AIDS , vol.11 , pp. 87-98
    • Burton, D.R.1    Montefiori, D.C.2
  • 14
    • 0028847578 scopus 로고
    • Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
    • Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
    • (1995) N. Engl. J. Med. , vol.332 , pp. 201-208
    • Cao, Y.1    Qin, L.2    Zhang, L.3    Safrit, J.4    Ho, D.D.5
  • 15
    • 0032505017 scopus 로고    scopus 로고
    • Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection
    • Carotenuto, P., D. Looij, L. Keldermans, F. de Wolf, and J. Goudsmit. 1998. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection. AIDS 12:1591-1600.
    • (1998) AIDS , vol.12 , pp. 1591-1600
    • Carotenuto, P.1    Looij, D.2    Keldermans, L.3    De Wolf, F.4    Goudsmit, J.5
  • 16
    • 0030842609 scopus 로고    scopus 로고
    • Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies
    • Chackerian, B., L. M. Rudensey, and J. Overbaugh. 1997. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 71:7719-7727.
    • (1997) J. Virol. , vol.71 , pp. 7719-7727
    • Chackerian, B.1    Rudensey, L.M.2    Overbaugh, J.3
  • 17
    • 0033033625 scopus 로고    scopus 로고
    • Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
    • Cheng-Mayer, C., A. Brown, J. Harouse, P. A. Luciw, and A. J. Mayer. 1999. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 73:5294-5300.
    • (1999) J. Virol. , vol.73 , pp. 5294-5300
    • Cheng-Mayer, C.1    Brown, A.2    Harouse, J.3    Luciw, P.A.4    Mayer, A.J.5
  • 18
    • 0037379188 scopus 로고    scopus 로고
    • The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C
    • Cilliers, T., J. Nhlapo, M. Coetzer, D. Orlovic, T. Ketas, W. C. Olson, J. P. Moore, A. Trkola, and L. Morris. 2003. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J. Virol. 77:4449-4456.
    • (2003) J. Virol. , vol.77 , pp. 4449-4456
    • Cilliers, T.1    Nhlapo, J.2    Coetzer, M.3    Orlovic, D.4    Ketas, T.5    Olson, W.C.6    Moore, J.P.7    Trkola, A.8    Morris, L.9
  • 19
    • 0036329849 scopus 로고    scopus 로고
    • Cell surface receptors, virus entry and tropism of primate lentiviruses
    • Clapham, P. R., and A. McKnight. 2002. Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 83:1809-1829.
    • (2002) J. Gen. Virol. , vol.83 , pp. 1809-1829
    • Clapham, P.R.1    McKnight, A.2
  • 20
    • 1442355578 scopus 로고    scopus 로고
    • HIV drug resistance
    • Clavel, F., and A. J. Hance. 2004. HIV drug resistance. N. Engl. J. Med. 350:1023-1035.
    • (2004) N. Engl. J. Med. , vol.350 , pp. 1023-1035
    • Clavel, F.1    Hance, A.J.2
  • 21
    • 0029417004 scopus 로고
    • Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
    • Cocchi, F., A. L. DeVico, A. Garzino-Derno, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
    • (1995) Science , vol.270 , pp. 1811-1815
    • Cocchi, F.1    DeVico, A.L.2    Garzino-Derno, A.3    Arya, S.K.4    Gallo, R.C.5    Lusso, P.6
  • 22
    • 0028952146 scopus 로고
    • HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy
    • Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
    • (1995) Science , vol.267 , pp. 483-489
    • Coffin, J.M.1
  • 23
    • 0025016076 scopus 로고
    • High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates
    • Daar, E. S., X. L. Li, T. Moudgil, and D. D. Ho. 1990. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 87:6574-6578.
    • (1990) Proc. Natl. Acad. Sci. USA , vol.87 , pp. 6574-6578
    • Daar, E.S.1    Li, X.L.2    Moudgil, T.3    Ho, D.D.4
  • 25
    • 0033856458 scopus 로고    scopus 로고
    • Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
    • Derdeyn, C. A., J. M. Decker, J. N. Sfakianos, X. Wu, W. A. O'Brien, L. Ratner, J. C. Kappes, G. M. Shaw, and E. Hunter. 2000. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74:8358-8367.
    • (2000) J. Virol. , vol.74 , pp. 8358-8367
    • Derdeyn, C.A.1    Decker, J.M.2    Sfakianos, J.N.3    Wu, X.4    O'Brien, W.A.5    Ratner, L.6    Kappes, J.C.7    Shaw, G.M.8    Hunter, E.9
  • 26
    • 0034890660 scopus 로고    scopus 로고
    • Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor
    • Derdeyn, C. A., J. M. Decker, J. N. Sfakianos, Z. Zhang, W. A. O'Brien, L. Ratner, G. M. Shaw, and E. Hunter. 2001. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor. J. Virol. 75:8605-8614.
    • (2001) J. Virol. , vol.75 , pp. 8605-8614
    • Derdeyn, C.A.1    Decker, J.M.2    Sfakianos, J.N.3    Zhang, Z.4    O'Brien, W.A.5    Ratner, L.6    Shaw, G.M.7    Hunter, E.8
  • 28
    • 0032849335 scopus 로고    scopus 로고
    • Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo
    • Etemad-Moghadam, B., Y. Sun, E. K. Nicholson, G. B. Karlsson, D. Schenten, and J. Sodroski. 1999. Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo. J. Virol. 73:8873-8879.
    • (1999) J. Virol. , vol.73 , pp. 8873-8879
    • Etemad-Moghadam, B.1    Sun, Y.2    Nicholson, E.K.3    Karlsson, G.B.4    Schenten, D.5    Sodroski, J.6
  • 35
    • 0031900546 scopus 로고    scopus 로고
    • CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates
    • Gauduin, M. C., G. P. Allaway, W. C. Olson, R. Weir, P. J. Maddon, and R. A. Koup. 1998. CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates. J. Virol. 72:3475-3478.
    • (1998) J. Virol. , vol.72 , pp. 3475-3478
    • Gauduin, M.C.1    Allaway, G.P.2    Olson, W.C.3    Weir, R.4    Maddon, P.J.5    Koup, R.A.6
  • 37
    • 0025958022 scopus 로고
    • Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody
    • Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N. C. Sun, and J. E. Robinson. 1991. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
    • (1991) J. Virol. , vol.65 , pp. 489-493
    • Ho, D.D.1    McKeating, J.A.2    Li, X.L.3    Moudgil, T.4    Daar, E.S.5    Sun, N.C.6    Robinson, J.E.7
  • 41
    • 0141617472 scopus 로고    scopus 로고
    • Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection
    • Koning, F. A., D. Kwa, B. Boeser-Nunnink, J. Dekker, J. Vingerhoed, H. Hiemstra, and H. Schuitemaker. 2003. Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection. J. Infect. Dis. 188:864-872.
    • (2003) J. Infect. Dis. , vol.188 , pp. 864-872
    • Koning, F.A.1    Kwa, D.2    Boeser-Nunnink, B.3    Dekker, J.4    Vingerhoed, J.5    Hiemstra, H.6    Schuitemaker, H.7
  • 42
    • 0031031452 scopus 로고    scopus 로고
    • CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
    • Kozak, S. L., E. J. Platt, N. Madani, F. E. Ferro, Jr., K. Peden, and D. Kabat. 1997. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J. Virol. 71:873-882.
    • (1997) J. Virol. , vol.71 , pp. 873-882
    • Kozak, S.L.1    Platt, E.J.2    Madani, N.3    Ferro Jr., F.E.4    Peden, K.5    Kabat, D.6
  • 43
    • 0036139211 scopus 로고    scopus 로고
    • MEGA2: Molecular evolutionary genetics analysis software
    • Kumar, S., K. Tamura, I. B. Jakobsen, and M. Nei. 2001. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245.
    • (2001) Bioinformatics , vol.17 , pp. 1244-1245
    • Kumar, S.1    Tamura, K.2    Jakobsen, I.B.3    Nei, M.4
  • 45
    • 0032543307 scopus 로고    scopus 로고
    • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
    • Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
    • (1998) Nature , vol.393 , pp. 648-659
    • Kwong, P.D.1    Wyatt, R.2    Robinson, J.3    Sweet, R.W.4    Sodroski, J.5    Hendrickson, W.A.6
  • 50
    • 0025292252 scopus 로고
    • Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
    • Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
    • (1990) J. Biol. Chem. , vol.265 , pp. 10373-10382
    • Leonard, C.K.1    Spellman, M.W.2    Riddle, L.3    Harris, R.J.4    Thomas, J.N.5    Gregory, T.J.6
  • 51
    • 0027535672 scopus 로고
    • Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding
    • Li, Y., L. Luo, N. Rasool, and C. Y. Kang. 1993. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J. Virol. 67:584-588.
    • (1993) J. Virol. , vol.67 , pp. 584-588
    • Li, Y.1    Luo, L.2    Rasool, N.3    Kang, C.Y.4
  • 53
    • 0033555025 scopus 로고    scopus 로고
    • HIV vaccines. Magic of the occult?
    • Montefiori, D., and J. P. Moore. 1999. HIV vaccines. Magic of the occult? Science 283:336-337.
    • (1999) Science , vol.283 , pp. 336-337
    • Montefiori, D.1    Moore, J.P.2
  • 54
    • 0034785811 scopus 로고    scopus 로고
    • Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection
    • Montefiori, D. C., T. S. Hill, H. T. Vo, B. D. Walker, and E. S. Rosenberg. 2001. Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection. J. Virol. 75:10200-10207.
    • (2001) J. Virol. , vol.75 , pp. 10200-10207
    • Montefiori, D.C.1    Hill, T.S.2    Vo, H.T.3    Walker, B.D.4    Rosenberg, E.S.5
  • 55
    • 0030057730 scopus 로고    scopus 로고
    • Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors
    • Montefiori, D. C., G. Pantaleo, L. M. Fink, J. T. Zhou, J. Y. Zhou, M. Bilska, G. D. Miralles, and A. S. Fauci. 1996. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect. Dis. 173:60-67.
    • (1996) J. Infect. Dis. , vol.173 , pp. 60-67
    • Montefiori, D.C.1    Pantaleo, G.2    Fink, L.M.3    Zhou, J.T.4    Zhou, J.Y.5    Bilska, M.6    Miralles, G.D.7    Fauci, A.S.8
  • 56
    • 0027168953 scopus 로고
    • Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4
    • Moore, J. P., L. C. Burkly, R. I. Connor, Y. Cao, R. Tizard, D. D. Ho, and R. A. Fisher. 1993. Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4. AIDS Res. Hum. Retroviruses 9:529-539.
    • (1993) AIDS Res. Hum. Retroviruses , vol.9 , pp. 529-539
    • Moore, J.P.1    Burkly, L.C.2    Connor, R.I.3    Cao, Y.4    Tizard, R.5    Ho, D.D.6    Fisher, R.A.7
  • 57
    • 0026601827 scopus 로고
    • Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
    • Moore, J. P., J. A. McKeating, Y. X. Huang, A. Ashkenazi, and D. D. Ho. 1992. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66:235-243.
    • (1992) J. Virol. , vol.66 , pp. 235-243
    • Moore, J.P.1    McKeating, J.A.2    Huang, Y.X.3    Ashkenazi, A.4    Ho, D.D.5
  • 58
    • 0030043169 scopus 로고    scopus 로고
    • Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
    • Moore, J. P., and J. Sodroski. 1996. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol. 70:1863-1872.
    • (1996) J. Virol. , vol.70 , pp. 1863-1872
    • Moore, J.P.1    Sodroski, J.2
  • 60
    • 0025253819 scopus 로고
    • Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding
    • Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:5701-5707.
    • (1990) J. Virol. , vol.64 , pp. 5701-5707
    • Olshevsky, U.1    Helseth, E.2    Furman, C.3    Li, J.4    Haseltine, W.5    Sodroski, J.6
  • 63
    • 0037213247 scopus 로고    scopus 로고
    • Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120
    • Pantophlet, R., E. Ollmann Saphire, P. Poignard, P. W. Parren, I. A. Wilson, and D. R. Burton. 2003. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J. Virol. 77:642-658.
    • (2003) J. Virol. , vol.77 , pp. 642-658
    • Pantophlet, R.1    Ollmann Saphire, E.2    Poignard, P.3    Parren, P.W.4    Wilson, I.A.5    Burton, D.R.6
  • 64
    • 0034864776 scopus 로고    scopus 로고
    • Antibody protects macaques against vaginal challenge with a pathogenic RS simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
    • Parren, P. W., P. A. Marx, A. J. Hessell, A. Luckay, J. Harouse, C. Cheng-Mayer, J. P. Moore, and D. R. Burton. 2001. Antibody protects macaques against vaginal challenge with a pathogenic RS simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75:8340-8347.
    • (2001) J. Virol. , vol.75 , pp. 8340-8347
    • Parren, P.W.1    Marx, P.A.2    Hessell, A.J.3    Luckay, A.4    Harouse, J.5    Cheng-Mayer, C.6    Moore, J.P.7    Burton, D.R.8
  • 65
    • 0000604395 scopus 로고    scopus 로고
    • The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity
    • Parren, P. W., J. P. Moore, D. R. Burton, and Q. J. Sattentau. 1999. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS 13:5137-5162.
    • (1999) AIDS , vol.13 , pp. 5137-5162
    • Parren, P.W.1    Moore, J.P.2    Burton, D.R.3    Sattentau, Q.J.4
  • 68
    • 0031954686 scopus 로고    scopus 로고
    • Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1
    • Platt, E., K. Wehrly, S. Kuhmann, B. Chesebro, and D. Rabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72:2855-2864.
    • (1998) J. Virol. , vol.72 , pp. 2855-2864
    • Platt, E.1    Wehrly, K.2    Kuhmann, S.3    Chesebro, B.4    Rabat, D.5
  • 69
    • 0031014643 scopus 로고    scopus 로고
    • Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor
    • Platt, E. J., N. Madani, S. L. Kozak, and D. Kabat. 1997. Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor. J. Virol. 71:883-890.
    • (1997) J. Virol. , vol.71 , pp. 883-890
    • Platt, E.J.1    Madani, N.2    Kozak, S.L.3    Kabat, D.4
  • 70
    • 1642377363 scopus 로고    scopus 로고
    • The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4
    • Pugach, P., S. E. Kuhmann, J. Taylor, A. J. Marozsan, A. Snyder, T. Ketas, S. M. Wolinsky, B. T. Korber, and J. P. Moore. 2004. The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4. Virology 321:8-22.
    • (2004) Virology , vol.321 , pp. 8-22
    • Pugach, P.1    Kuhmann, S.E.2    Taylor, J.3    Marozsan, A.J.4    Snyder, A.5    Ketas, T.6    Wolinsky, S.M.7    Korber, B.T.8    Moore, J.P.9
  • 73
    • 0036229473 scopus 로고    scopus 로고
    • Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: Effects on protein function and the neutralizing antibody response
    • Quinones-Kochs, M. I., L. Buonocore, and J. R. Rose. 2002. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. J. Virol. 76:4199-4211.
    • (2002) J. Virol. , vol.76 , pp. 4199-4211
    • Quinones-Kochs, M.I.1    Buonocore, L.2    Rose, J.R.3
  • 75
    • 0031749469 scopus 로고    scopus 로고
    • A role for carbohydrates in immune evasion in AIDS
    • Reitter, J. N., R. E. Means, and R. C. Desrosiers. 1998. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4:679-684.
    • (1998) Nat. Med. , vol.4 , pp. 679-684
    • Reitter, J.N.1    Means, R.E.2    Desrosiers, R.C.3
  • 76
    • 0037389643 scopus 로고    scopus 로고
    • Rapid evolution of the neutralizing antibody response to HIV type 1 infection
    • Richman, D. D., T. Wrin, S. J. Little, and C. J. Petropoulos. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100:4144-4149.
    • (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 4144-4149
    • Richman, D.D.1    Wrin, T.2    Little, S.J.3    Petropoulos, C.J.4
  • 77
    • 0031883832 scopus 로고    scopus 로고
    • Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides
    • Rimsky, L. T., D. C. Shugars, and T. J. Matthews. 1998. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72:986-993.
    • (1998) J. Virol. , vol.72 , pp. 986-993
    • Rimsky, L.T.1    Shugars, D.C.2    Matthews, T.J.3
  • 78
    • 0028291731 scopus 로고
    • Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1
    • Roben, P., J. P. Moore, M. Thali, J. Sodroski, C. F. Barbas III, and D. R. Burton. 1994. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68:4821-4828.
    • (1994) J. Virol. , vol.68 , pp. 4821-4828
    • Roben, P.1    Moore, J.P.2    Thali, M.3    Sodroski, J.4    Barbas III, C.F.5    Burton, D.R.6
  • 79
    • 0042237921 scopus 로고    scopus 로고
    • RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement
    • Roscic-Mrkic, B., M. Fischer, C. Leemann, A. Manrique, C. J. Gordon, J. P. Moore, A. E. Proudfoot, and A. Trkola. 2003. RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 102:1169-1177.
    • (2003) Blood , vol.102 , pp. 1169-1177
    • Roscic-Mrkic, B.1    Fischer, M.2    Leemann, C.3    Manrique, A.4    Gordon, C.J.5    Moore, J.P.6    Proudfoot, A.E.7    Trkola, A.8
  • 80
    • 0036637385 scopus 로고    scopus 로고
    • The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
    • Sanders, R. W., M. Venturi, L. Schifner, R. Ralyanaraman, H. Katinger, K. O. Lloyd, P. D. Kwong, and J. P. Moore. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305.
    • (2002) J. Virol. , vol.76 , pp. 7293-7305
    • Sanders, R.W.1    Venturi, M.2    Schifner, L.3    Ralyanaraman, R.4    Katinger, H.5    Lloyd, K.O.6    Kwong, P.D.7    Moore, J.P.8
  • 81
    • 18244422922 scopus 로고    scopus 로고
    • The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizȩs a cluster of alphal→2 mannose residues on the outer face of gp120
    • Scanlan, C. N., R. Pantophlet, M. R. Wormald, E. Ollmann Saphire, R. Stanfield, I. A. Wilson, H. Ratinger, R. A. Dwek, P. M. Rudd, and D. R. Burton. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizȩs a cluster of alphal→2 mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
    • (2002) J. Virol. , vol.76 , pp. 7306-7321
    • Scanlan, C.N.1    Pantophlet, R.2    Wormald, M.R.3    Ollmann Saphire, E.4    Stanfield, R.5    Wilson, I.A.6    Ratinger, H.7    Dwek, R.A.8    Rudd, P.M.9    Burton, D.R.10
  • 82
    • 0032907674 scopus 로고    scopus 로고
    • Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HTV-1/SIV chimeric virus infections of macaque monkeys
    • Shibata, R., T. Igarashi, N. Haigwood, A. Buckler-White, R. Ogert, W. Ross, R. Willey, M. W. Cho, and M. A. Martin. 1999. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HTV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5:204-210.
    • (1999) Nat. Med. , vol.5 , pp. 204-210
    • Shibata, R.1    Igarashi, T.2    Haigwood, N.3    Buckler-White, A.4    Ogert, R.5    Ross, W.6    Willey, R.7    Cho, M.W.8    Martin, M.A.9
  • 83
    • 0035046931 scopus 로고    scopus 로고
    • Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys
    • Si, Z., M. Cayabyab, and J. Sodroski. 2001. Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys. J. Virol. 75: 4208-4218.
    • (2001) J. Virol. , vol.75 , pp. 4208-4218
    • Si, Z.1    Cayabyab, M.2    Sodroski, J.3
  • 84
    • 0035701421 scopus 로고    scopus 로고
    • A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
    • Stiegler, G., R. Kunert, M. Purtscher, S. Wolbank, R. Voglauer, F. Steindl, and H. Katinger. 2001. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 17:1757-1765.
    • (2001) AIDS Res. Hum. Retroviruses , vol.17 , pp. 1757-1765
    • Stiegler, G.1    Kunert, R.2    Purtscher, M.3    Wolbank, S.4    Voglauer, R.5    Steindl, F.6    Katinger, H.7
  • 86
    • 0027256814 scopus 로고
    • Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
    • Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
    • (1993) J. Virol. , vol.67 , pp. 3978-3988
    • Thali, M.1    Moore, J.P.2    Furman, C.3    Charles, M.4    Ho, D.D.5    Robinson, J.6    Sodroski, J.7
  • 87
    • 0024549563 scopus 로고
    • Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules
    • Traunecker, A., J. Schneider, H. Kiefer, and K. Karjalainen. 1989. Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature 339:68-70.
    • (1989) Nature , vol.339 , pp. 68-70
    • Traunecker, A.1    Schneider, J.2    Kiefer, H.3    Karjalainen, K.4
  • 89
    • 0032768967 scopus 로고    scopus 로고
    • The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity
    • Trkola, A., C. Gordon, J. Matthews, E. Maxwell, T. Ketas, L. Czaplewski, A. E. Proudfoot, and J. P. Moore. 1999. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J. Virol. 73:6370-6379.
    • (1999) J. Virol. , vol.73 , pp. 6370-6379
    • Trkola, A.1    Gordon, C.2    Matthews, J.3    Maxwell, E.4    Ketas, T.5    Czaplewski, L.6    Proudfoot, A.E.7    Moore, J.P.8
  • 90
    • 0031936306 scopus 로고    scopus 로고
    • Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage
    • Trkola, A., T. Ketas, V. N. Kewalramani, F. Endorf, J. M. Binley, H. Katinger, J. Robinson, D. R. Littman, and J. P. Moore. 1998. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J. Virol. 72:1876-1885.
    • (1998) J. Virol. , vol.72 , pp. 1876-1885
    • Trkola, A.1    Ketas, T.2    Kewalramani, V.N.3    Endorf, F.4    Binley, J.M.5    Katinger, H.6    Robinson, J.7    Littman, D.R.8    Moore, J.P.9
  • 95
    • 0032828730 scopus 로고    scopus 로고
    • A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor
    • Trkola, A., J. Matthews, C. Gordon, T. Ketas, and J. P. Moore. 1999. A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J. Virol. 73:8966-8974.
    • (1999) J. Virol. , vol.73 , pp. 8966-8974
    • Trkola, A.1    Matthews, J.2    Gordon, C.3    Ketas, T.4    Moore, J.P.5
  • 97
    • 0028865465 scopus 로고
    • Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG
    • Trkola, A., A. B. Pomales, H. Yuan, B. Korber, P. J. Maddon, G. P. Allaway, H. Katinger, C. F. r. Barbas, D. R. Burton, D. D. Ho, et al. 1995. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 69: 6609-6617.
    • (1995) J. Virol. , vol.69 , pp. 6609-6617
    • Trkola, A.1    Pomales, A.B.2    Yuan, H.3    Korber, B.4    Maddon, P.J.5    Allaway, G.P.6    Katinger, H.7    Barbas, C.F.R.8    Burton, D.R.9    Ho, D.D.10
  • 100
    • 0026543737 scopus 로고
    • Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120
    • Turner, S., R. Tizard, J. DeMarinis, R. B. Pepinsky, J. Zullo, R. Schooley, and R. Fisher. 1992. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89:1335-1339.
    • (1992) Proc. Natl. Acad. Sci. USA , vol.89 , pp. 1335-1339
    • Turner, S.1    Tizard, R.2    DeMarinis, J.3    Pepinsky, R.B.4    Zullo, J.5    Schooley, R.6    Fisher, R.7
  • 102
    • 0022524810 scopus 로고
    • Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus
    • Willey, R. L., R. A. Rutledge, S. Dias, T. Folks, T. Theodore, C. E. Buckier, and M. A. Martin. 1986. Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc. Natl. Acad. Sci. USA 83:5038-5042.
    • (1986) Proc. Natl. Acad. Sci. USA , vol.83 , pp. 5038-5042
    • Willey, R.L.1    Rutledge, R.A.2    Dias, S.3    Folks, T.4    Theodore, T.5    Buckier, C.E.6    Martin, M.A.7
  • 104
    • 0028966078 scopus 로고
    • Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera
    • Wrin, T., T. P. Loh, J. C. Vennari, H. Schuitemaker, and J. H. Nunberg. 1995. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69:39-48.
    • (1995) J. Virol. , vol.69 , pp. 39-48
    • Wrin, T.1    Loh, T.P.2    Vennari, J.C.3    Schuitemaker, H.4    Nunberg, J.H.5
  • 106
    • 0034687168 scopus 로고    scopus 로고
    • Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells
    • Zhu, X., C. Borchers, R. J. Bienstock, and K. B. Tomer. 2000. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39:11194-11204.
    • (2000) Biochemistry , vol.39 , pp. 11194-11204
    • Zhu, X.1    Borchers, C.2    Bienstock, R.J.3    Tomer, K.B.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.